Mesopic Visual Acuity Evaluation After Cataract Surgery In Patients Implanted With A Novel Full Visual Range Intraocular Lens.
Published 2025 - 43rd Congress of the ESCRS
Reference: PO402 | Type: Free paper | DOI: 10.82333/k99y-nb29
Authors: Josefina Botta* 1 , OMAR RUIZ 1 , GUSTAVO GALPERIN 2 , IGNACIO BUSCH 1
1RB VISION,BUENOS AIRES,Argentina, 2CONSULTORIOS GALPERIN,BUENOS AIRES,Argentina
Purpose
The aim of this study is to assess the mesopic monocular and binocular visual acuity outcomes after cataract surgery with implantation of a novel Full Visual Range (FVR) enVista intraocular lens (IOL) or its parent monofocal IOL in US subjects.
Setting
23 US clinical sites
Methods
Data from this prospective, multicenter, randomized, controlled clinical trial evaluated outcomes after bilateral implantation of a novel full visual range (FVR) enVista Envy IOL (Bausch + Lomb) (study group, n=284) or a monofocal enVista IOL (control group, n=142) in patients undergoing cataract surgery. Distance-corrected monocular and binocular visual acuity at intermediate (DCIVA, 66 cm) and near (DCNVA, 40 cm) under mesopic conditions at 120-180 days post-surgery was assessed.
Results
At 120-180 days post-surgery, the mean monocular and binocular mesopic DCIVA was significantly better in the FVR group (0.29±0.14 vs 0.46±0.16 logMAR and 0.21±0.12 vs 0.39±0.13logMAR, respectively) than in the monocular group (both p>0.0001). Likewise, the mean mesopic DCNVA was also significantly better in the FVR group (monocular 0.35±+0.15 logMAR vs 0.66±0.18 logMAR and binocular 0.26±0.13 vs 0.59±0.15 logMAR) compared to monofocal group (both p>0.0001).
Conclusions
enVista Envy FVR IOL demonstrated good efficacy under mesopic conditions achieving good binocular DCIVA (20/32) and DCNVA (20/37). Patients implanted with the FVR IOL showed a mean binocular DCIVA of more than 2 lines better and a mean DCNVA of 4 lines better than the monofocal group.